Respimat Inhaler Heart Risk Higher Than That of Spiriva: Researchers
A new study raises concerns that Respimat, as soft mist inhaler, may carry more heart risk than Spiriva.
February 03, 2014 By: Irvin Jackson
A new study raises concerns that Respimat, as soft mist inhaler, may carry more heart risk than Spiriva.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.
A federal judge has ordered the CEO of 3M Company to attend settlement negotiations over Combat Arms earplugs hearing loss litigation.
Plaintiffs have filed a Master Complaint in consolidated hair relaxer litigation, which will help make direct filing of cases to the MDL court easier.